Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lyofiliseret pulver til injicerbar suspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Powder for prolonged-release suspension for injection (dose form) |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
lyofiliseret pulver til injicerbar liposomal depotsuspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
lyofiliseret pulver til injicerbar liposomal suspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
leuprorelinacetat 7,5 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
leuprorelinacetat 30 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
leuprorelinacetat 11,25 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
leuprorelinacetat 22,5 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Olanzapine 300mg powder for injection suspension |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Olanzapine 210mg powder for injection suspension |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Olanzapine 405mg powder for injection suspension |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
leuprorelinacetat 45 mg pulver til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Paclitaxel 100 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Risperidone 12.5 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Risperidone 50 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Benzathine benzylpenicillin 2.4 million unit powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
pulver og solvent til injektionsvæske, suspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
pulver til injektionsvæske, opløsning/suspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
pulver og solvent til injektionsvæske |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|